Cargando…

Translational Approaches with Antioxidant Phytochemicals against Alcohol-Mediated Oxidative Stress, Gut Dysbiosis, Intestinal Barrier Dysfunction, and Fatty Liver Disease

Emerging data demonstrate the important roles of altered gut microbiomes (dysbiosis) in many disease states in the peripheral tissues and the central nervous system. Gut dysbiosis with decreased ratios of Bacteroidetes/Firmicutes and other changes are reported to be caused by many disease states and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ballway, Jacob W., Song, Byoung-Joon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8000766/ https://www.ncbi.nlm.nih.gov/pubmed/33806556 http://dx.doi.org/10.3390/antiox10030384

Ejemplares similares

Implication of Intestinal Barrier Dysfunction in Gut Dysbiosis and Diseases
por: Stolfi, Carmine, et al.
Publicado: (2022)

Microbiota Dysbiosis and Gut Barrier Dysfunction Associated with Non-Alcoholic Fatty Liver Disease Are Modulated by a Specific Metabolic Cofactors’ Combination
por: Quesada-Vázquez, Sergio, et al.
Publicado: (2022)

Gut Dysbiosis and Intestinal Barrier Dysfunction: Potential Explanation for Early-Onset Colorectal Cancer
por: Ahmad Kendong, Siti Maryam, et al.
Publicado: (2021)

Intestinal Microbiome Shifts, Dysbiosis, Inflammation, and Non-alcoholic Fatty Liver Disease
por: Saltzman, Emma T., et al.
Publicado: (2018)

Dysbiosis of Gut Microbiota and Intestinal Barrier Dysfunction in Pigs with Pulmonary Inflammation Induced by Mycoplasma hyorhinis Infection
por: Zhang, Yingying, et al.
Publicado: (2022)

Dysbiosis gut microbiota associated with inflammation and impaired mucosal immune function in intestine of humans with non-alcoholic fatty liver disease
por: Jiang, Weiwei, et al.
Publicado: (2015)

Dysbiosis, gut barrier dysfunction and inflammation in dementia: a pilot study
por: Stadlbauer, Vanessa, et al.
Publicado: (2020)

The Role of Gut Barrier Dysfunction and Microbiome Dysbiosis in Colorectal Cancer Development
por: Genua, Flavia, et al.
Publicado: (2021)

Piglet cardiopulmonary bypass induces intestinal dysbiosis and barrier dysfunction associated with systemic inflammation
por: Salomon, Jeffrey D., et al.
Publicado: (2023)

Dysbiosis of gut microbiota after cholecystectomy is associated with non‐alcoholic fatty liver disease in mice
por: Wang, Qihan, et al.
Publicado: (2021)

Alcohol-dependent downregulation of apolipoprotein H exacerbates fatty liver and gut microbiota dysbiosis in mice
por: Liu, Yaming, et al.
Publicado: (2022)

The Intestinal Barrier and Its Dysfunction in Patients with Metabolic Diseases and Non-Alcoholic Fatty Liver Disease
por: Forlano, Roberta, et al.
Publicado: (2022)

Gut Dysbiosis and Intestinal Barrier Dysfunction Promotes IgA Nephropathy by Increasing the Production of Gd-IgA1
por: Tang, Yuyan, et al.
Publicado: (2022)

Gut Dysfunction and Non-alcoholic Fatty Liver Disease
por: Grabherr, Felix, et al.
Publicado: (2019)

From intestinal dysbiosis to alcohol-associated liver disease
por: Mendes, Beatriz Garcia, et al.
Publicado: (2020)

Distinctive gut microbial dysbiosis between chronic alcoholic fatty liver disease and metabolic-associated fatty liver disease in mice
por: Kang, Kai, et al.
Publicado: (2021)

Taraxasterol ameliorates dextran sodium sulfate-induced murine colitis via improving intestinal barrier and modulating gut microbiota dysbiosis: Taraxasterol ameliorates colitis via intestinal barrier and gut microbiota dysbiosis
por: Li, Chen, et al.
Publicado: (2022)

Diet-Induced Non-alcoholic Fatty Liver Disease and Associated Gut Dysbiosis Are Exacerbated by Oral Infection
por: Simas, Alexandra M., et al.
Publicado: (2022)

Oral and Gut Microbial Dysbiosis and Non-alcoholic Fatty Liver Disease: The Central Role of Porphyromonas gingivalis
por: Wang, Ting, et al.
Publicado: (2022)

Alterations of nitric oxide homeostasis as trigger of intestinal barrier dysfunction in non‐alcoholic fatty liver disease
por: Baumann, Anja, et al.
Publicado: (2022)

Bile Acids and Dysbiosis in Non-Alcoholic Fatty Liver Disease
por: Mouzaki, Marialena, et al.
Publicado: (2016)

Ellagic Acid Prevents Binge Alcohol-Induced Leaky Gut and Liver Injury through Inhibiting Gut Dysbiosis and Oxidative Stress
por: Kim, Dong-ha, et al.
Publicado: (2021)

Gut dysbiosis as a driver in alcohol-induced liver injury
por: Fairfield, Bradley, et al.
Publicado: (2020)

Rhubarb Enema Increasing Short-Chain Fatty Acids that Improves the Intestinal Barrier Disruption in CKD May Be Related to the Regulation of Gut Dysbiosis
por: Ji, Chunlan, et al.
Publicado: (2022)

Gut microbiota dysbiosis involves in host non-alcoholic fatty liver disease upon pyrethroid pesticide exposure
por: Li, Meng, et al.
Publicado: (2022)

The Role of Gut-Derived Lipopolysaccharides and the Intestinal Barrier in Fatty Liver Diseases
por: An, Lingxuan, et al.
Publicado: (2021)

Heat stress-induced mucosal barrier dysfunction is potentially associated with gut microbiota dysbiosis in pigs
por: Xia, Bing, et al.
Publicado: (2021)

Dysbiosis and Intestinal Barrier Dysfunction in Pediatric Congenital Heart Disease Is Exacerbated Following Cardiopulmonary Bypass
por: Salomon, Jeffrey, et al.
Publicado: (2021)

Polymeric immunoglobulin receptor deficiency exacerbates autoimmune hepatitis by inducing intestinal dysbiosis and barrier dysfunction
por: Lin, Hongwei, et al.
Publicado: (2023)

Naringin Attenuates High Fat Diet Induced Non-alcoholic Fatty Liver Disease and Gut Bacterial Dysbiosis in Mice
por: Mu, Hongna, et al.
Publicado: (2020)

Orthopedic Surgery Causes Gut Microbiome Dysbiosis and Intestinal Barrier Dysfunction in Prodromal Alzheimer Disease Patients: A Prospective Observational Cohort Study
por: Liu, Fangyan, et al.
Publicado: (2022)

Intestinal barrier dysfunction in murine sickle cell disease is associated with small intestine neutrophilic inflammation, oxidative stress, and dysbiosis
por: Lewis, Caitlin V., et al.
Publicado: (2023)

Significance of gut microbiota in alcoholic and non-alcoholic fatty liver diseases
por: Sharma, Satya Priya, et al.
Publicado: (2021)

Gut Microbiome Dysbiosis in Alcoholism: Consequences for Health and Recovery
por: Day, Andrew Whittier, et al.
Publicado: (2022)

Antibiotic-Induced Gut Microbiota Dysbiosis Damages the Intestinal Barrier, Increasing Food Allergy in Adult Mice
por: Zhang, Qiuyu, et al.
Publicado: (2021)

Intestinal fatty acid binding protein is associated with cardiac function and gut dysbiosis in chronic heart failure
por: Nendl, Andraž, et al.
Publicado: (2023)

Partners in Leaky Gut Syndrome: Intestinal Dysbiosis and Autoimmunity
por: Kinashi, Yusuke, et al.
Publicado: (2021)

Correction: Polymeric immunoglobulin receptor deficiency exacerbates autoimmune hepatitis by inducing intestinal dysbiosis and barrier dysfunction
por: Lin, Hongwei, et al.
Publicado: (2023)

Gut dysbiosis in nonalcoholic fatty liver disease: pathogenesis, diagnosis, and therapeutic implications
por: Fang, Jie, et al.
Publicado: (2022)

Novel insights into non-alcoholic fatty liver disease and dementia: insulin resistance, hyperammonemia, gut dysbiosis, vascular impairment, and inflammation
por: Cheon, So Yeong, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_d872mth0jhq2teonp2c008qs5c